Teh Seng Pharmaceutical Mfg Co (ROCO:7860) Other Current Payables: NT$56.7 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:7860 Teh Seng Pharmaceutical Mfg Co Ltd ROCO:7860
22 GF Score
Price NT$73.10
! 7 Warning Signs
View Full Analysis

What is Teh Seng Pharmaceutical Mfg Co Other Current Payables?

Teh Seng Pharmaceutical Mfg Co ROCO:7860 -5.06% 22 Other Current Payables is NT$56.7 Mil as of Dec. 2025. GuruFocus rates ROCO:7860 with a GF Score™ of 22/100. The stock has 7 warning signs investors should review.

Teh Seng Pharmaceutical Mfg Co's Other Current Payables for the quarter that ended in Dec. 2025 was NT$56.7 Mil.

Teh Seng Pharmaceutical Mfg Co's quarterly Other Current Payables increased from Dec. 2024 (NT$58.1 Mil) to Jun. 2025 (NT$109.7 Mil) but then declined from Jun. 2025 (NT$109.7 Mil) to Dec. 2025 (NT$56.7 Mil).

Teh Seng Pharmaceutical Mfg Co's annual Other Current Payables declined from Dec. 2023 (NT$64.2 Mil) to Dec. 2024 (NT$58.1 Mil) and declined from Dec. 2024 (NT$58.1 Mil) to Dec. 2025 (NT$56.7 Mil).


Teh Seng Pharmaceutical Mfg Co Other Current Payables Related Terms


Teh Seng Pharmaceutical Mfg Co Other Current Payables Historical Data

* Premium members only.

The historical data trend for Teh Seng Pharmaceutical Mfg Co's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Teh Seng Pharmaceutical Mfg Co Other Current Payables Chart

Teh Seng Pharmaceutical Mfg Co Annual Data
Trend Dec23 Dec24 Dec25
Other Current Payables
64.18 58.09 56.75

Teh Seng Pharmaceutical Mfg Co Semi-Annual Data
Dec23 Jun24 Dec24 Jun25 Dec25
Other Current Payables 64.18 0.00 58.09 109.68 56.75
ROCO:7860
22GF Score
Teh Seng Pharmaceutical Mfg Co Ltd ROCO:7860
Other Current Payables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Teh Seng Pharmaceutical Mfg Co Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Frequently Asked Questions Learn more about Other Current Payables →
What does a Other Current Payables of NT$56.7 Mil mean?
Teh Seng Pharmaceutical Mfg Co (ROCO:7860) has a Other Current Payables of NT$56.7 Mil as of Dec. 2025. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Teh Seng Pharmaceutical Mfg Co and its competitors.
Is Teh Seng Pharmaceutical Mfg Co's Other Current Payables too high?
Teh Seng Pharmaceutical Mfg Co's current Other Current Payables is NT$56.7 Mil. Overall, Teh Seng Pharmaceutical Mfg Co has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Teh Seng Pharmaceutical Mfg Co's Other Current Payables compare to ZTS?
Teh Seng Pharmaceutical Mfg Co's Other Current Payables of NT$56.7 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Payables for a Drug Manufacturers company?
A good Other Current Payables depends on the Drug Manufacturers industry context. However, Other Current Payables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Payables mean?
A high Other Current Payables can signal that a stock is expensive relative to its fundamentals. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Teh Seng Pharmaceutical Mfg Co and its competitors. Teh Seng Pharmaceutical Mfg Co's current Other Current Payables is NT$56.7 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Teh Seng Pharmaceutical Mfg Co stock overvalued right now?
Teh Seng Pharmaceutical Mfg Co (ROCO:7860) has a current Other Current Payables of NT$56.7 Mil. The current Other Current Payables is NT$56.7 Mil. Teh Seng Pharmaceutical Mfg Co's overall GF Score™ is 22/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Payables calculated?
Other Current Payables is calculated from a company's financial statements. For Teh Seng Pharmaceutical Mfg Co (ROCO:7860), the current Other Current Payables is NT$56.7 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Teh Seng Pharmaceutical Mfg Co Business Description

Address No.42,Huan Gong Road, Yong Kang District, Tainan, TWN, 710001
Teh Seng Pharmaceutical Mfg Co Ltd is engaged in the development and manufacturing of various pain relieving patches, cosmetic patches and biotechnology products. Its products include: Hydrogel Patches, Oil-Based Patches, Hot-Melt Patches, CMO & CRO for Transdermal Patch, Oral Film & Sublingual, Cosmetic Patches, Biotechnology Products and Daily Supplements.
22GF Score

Get the complete analysis for ROCO:7860

Other Current Payables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$73.10
Price